XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Common Stock
Surplus
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Dec. 31, 2020 $ 177,434 $ 3,765,406 $ 657,451 $ 47,589 $ 4,647,880
Balance (in shares) at Dec. 31, 2020 70,973,477        
Increase (Decrease) in Stockholders' Equity          
Net income     245,909   245,909
Other comprehensive Income (loss), net of tax effects       (23,453) (23,453)
Total comprehensive income (loss)         222,456
Cash dividends declared on common stock per share     (66,685)   (66,685)
Cash dividends equivalents paid on restricted stock units     (91)   (91)
Employee stock purchases $ 18 466     484
Employee stock purchases (in shares) 7,097        
Stock options exercised $ 106 1,801     1,907
Stock options exercised (in shares) 42,697        
Stock issued pursuant to restricted stock units $ 180 (180)      
Stock issued pursuant to restricted stock units (in shares) 71,770        
Common stock repurchased - buyback plan $ (1,750) (58,411)     (60,161)
Common stock repurchased - buyback plan (in shares) (700,000)        
Common stock repurchased $ (31) (935)     (966)
Common stock repurchased (in shares) (12,313)        
Share-based compensation expense   12,799     12,799
Balance at Jun. 30, 2021 $ 175,957 3,720,946 836,584 24,136 4,757,623
Balance (in shares) at Jun. 30, 2021 70,382,728        
Balance at Mar. 31, 2021 $ 177,651 3,772,248 770,952 (1,031) 4,719,820
Balance (in shares) at Mar. 31, 2021 71,060,446        
Increase (Decrease) in Stockholders' Equity          
Net income     98,960   98,960
Other comprehensive Income (loss), net of tax effects       25,167 25,167
Total comprehensive income (loss)         124,127
Cash dividends declared on common stock per share     (33,305)   (33,305)
Cash dividends equivalents paid on restricted stock units     (23)   (23)
Employee stock purchases $ 18 466     484
Employee stock purchases (in shares) 7,097        
Stock options exercised $ 12 124     136
Stock options exercised (in shares) 4,843        
Stock issued pursuant to restricted stock units $ 31 (31)      
Stock issued pursuant to restricted stock units (in shares) 12,308        
Common stock repurchased - buyback plan $ (1,750) (58,411)     (60,161)
Common stock repurchased - buyback plan (in shares) (700,000)        
Common stock repurchased $ (5) (157)     (162)
Common stock repurchased (in shares) (1,966)        
Share-based compensation expense   6,707     6,707
Balance at Jun. 30, 2021 $ 175,957 3,720,946 836,584 24,136 4,757,623
Balance (in shares) at Jun. 30, 2021 70,382,728        
Balance at Dec. 31, 2021 $ 173,331 3,653,098 997,657 (21,146) $ 4,802,940
Balance (in shares) at Dec. 31, 2021 69,332,297       69,332,297
Increase (Decrease) in Stockholders' Equity          
Net income     219,504   $ 219,504
Other comprehensive Income (loss), net of tax effects       (469,738) (469,738)
Total comprehensive income (loss)         (250,234)
Cash dividends declared on common stock per share     (70,805)   (70,805)
Cash dividends equivalents paid on restricted stock units     (126)   (126)
Employee stock purchases $ 23 681     704
Employee stock purchases (in shares) 9,078        
Stock options exercised $ 45 692     737
Stock options exercised (in shares) 18,256        
Restricted stock awards $ (3) 3      
Restricted stock awards (in shares) (1,266)        
Stock issued pursuant to restricted stock units $ 912 (911)     1
Stock issued pursuant to restricted stock units (in shares) 364,809        
Common stock repurchased - buyback plan $ (3,280) (106,924)     (110,204)
Common stock repurchased - buyback plan (in shares) (1,312,038)        
Common stock repurchased $ (252) (7,927)     (8,179)
Common stock repurchased (in shares) (100,617)        
Share-based compensation expense   17,799     17,799
Common stock issued for acquisition $ 18,327 641,445     659,772
Common stock issued for acquisition (in shares) 7,330,803        
Net fair value of unvested equity awards assumed in the Atlantic Capital acquisition   (1,980)     (1,980)
Balance at Jun. 30, 2022 $ 189,103 4,195,976 1,146,230 (490,884) $ 5,040,425
Balance (in shares) at Jun. 30, 2022 75,641,322       75,641,322
Balance at Mar. 31, 2022 $ 189,403 4,214,897 1,064,064 (293,956) $ 5,174,408
Balance (in shares) at Mar. 31, 2022 75,761,018        
Increase (Decrease) in Stockholders' Equity          
Net income     119,175   119,175
Other comprehensive Income (loss), net of tax effects       (196,928) (196,928)
Total comprehensive income (loss)         (77,753)
Cash dividends declared on common stock per share     (36,983)   (36,983)
Cash dividends equivalents paid on restricted stock units     (26)   (26)
Employee stock purchases $ 23 681     704
Employee stock purchases (in shares) 9,078        
Stock options exercised $ 21 308     329
Stock options exercised (in shares) 8,553        
Restricted stock awards $ (3) 3      
Restricted stock awards (in shares) (1,266)        
Stock issued pursuant to restricted stock units $ 591 (590)     1
Stock issued pursuant to restricted stock units (in shares) 236,507        
Common stock repurchased - buyback plan $ (750) (22,996)     (23,746)
Common stock repurchased - buyback plan (in shares) (300,000)        
Common stock repurchased $ (182) (5,640)     (5,822)
Common stock repurchased (in shares) (72,568)        
Share-based compensation expense   9,313     9,313
Balance at Jun. 30, 2022 $ 189,103 $ 4,195,976 $ 1,146,230 $ (490,884) $ 5,040,425
Balance (in shares) at Jun. 30, 2022 75,641,322       75,641,322